Jeffrey E. Russel

Array ( [id] => 196774 [patent_doc_number] => 07638494 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-12-29 [patent_title] => 'G-type peptides to ameliorate atherosclerosis' [patent_app_type] => utility [patent_app_number] => 10/520207 [patent_app_country] => US [patent_app_date] => 2003-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 17115 [patent_no_of_claims] => 88 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/638/07638494.pdf [firstpage_image] =>[orig_patent_app_number] => 10520207 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 633868 [patent_doc_number] => 07128923 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-10-31 [patent_title] => 'Preserved and stable compositions containing peptide copper complexes and method related thereto' [patent_app_type] => utility [patent_app_number] => 10/405111 [patent_app_country] => US [patent_app_date] => 2003-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6787 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 258 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/128/07128923.pdf [firstpage_image] =>[orig_patent_app_number] => 10405111 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 774102 [patent_doc_number] => 07001982 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-02-21 [patent_title] => 'Non-natural C-linked carbo-β-peptides with robust secondary structures' [patent_app_type] => utility [patent_app_number] => 10/403815 [patent_app_country] => US [patent_app_date] => 2003-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 24518 [patent_no_of_claims] => 67 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 197 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/001/07001982.pdf [firstpage_image] =>[orig_patent_app_number] => 10403815 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6805367 [patent_doc_number] => 20030232761 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-18 [patent_title] => 'Novel analogues of glucose-dependent insulinotropic polypeptide' [patent_app_type] => new [patent_app_number] => 10/397160 [patent_app_country] => US [patent_app_date] => 2003-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 10800 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20030232761.pdf [firstpage_image] =>[orig_patent_app_number] => 10397160 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6825570 [patent_doc_number] => 20030236192 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-25 [patent_title] => 'Method of modifying the release profile of sustained release compositions' [patent_app_type] => new [patent_app_number] => 10/400162 [patent_app_country] => US [patent_app_date] => 2003-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9529 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0236/20030236192.pdf [firstpage_image] =>[orig_patent_app_number] => 10400162 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7385711 [patent_doc_number] => 20040082507 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-29 [patent_title] => 'Use of GLP-1 and GLP-2 peptides' [patent_app_type] => new [patent_app_number] => 10/391460 [patent_app_country] => US [patent_app_date] => 2003-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6257 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20040082507.pdf [firstpage_image] =>[orig_patent_app_number] => 10391460 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 793035 [patent_doc_number] => 06982080 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-01-03 [patent_title] => 'Hydroxyethyl starch—containing polypeptide compositions' [patent_app_type] => utility [patent_app_number] => 10/390053 [patent_app_country] => US [patent_app_date] => 2003-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 7850 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/982/06982080.pdf [firstpage_image] =>[orig_patent_app_number] => 10390053 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6639019 [patent_doc_number] => 20030211999 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-13 [patent_title] => 'Polypeptides containing gamma-amino acids' [patent_app_type] => new [patent_app_number] => 10/389500 [patent_app_country] => US [patent_app_date] => 2003-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 16282 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0211/20030211999.pdf [firstpage_image] =>[orig_patent_app_number] => 10389500 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7367488 [patent_doc_number] => 20040006049 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-08 [patent_title] => 'Novel polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseases' [patent_app_type] => new [patent_app_number] => 10/385224 [patent_app_country] => US [patent_app_date] => 2003-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 67 [patent_figures_cnt] => 67 [patent_no_of_words] => 48253 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0006/20040006049.pdf [firstpage_image] =>[orig_patent_app_number] => 10385224 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 963702 [patent_doc_number] => 06949514 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-09-27 [patent_title] => 'Anti-tumor agents' [patent_app_type] => utility [patent_app_number] => 10/384121 [patent_app_country] => US [patent_app_date] => 2003-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 11 [patent_no_of_words] => 18017 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/949/06949514.pdf [firstpage_image] =>[orig_patent_app_number] => 10384121 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7367024 [patent_doc_number] => 20040005999 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-08 [patent_title] => 'Polyamino acid-based particle insulin preparation' [patent_app_type] => new [patent_app_number] => 10/384105 [patent_app_country] => US [patent_app_date] => 2003-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4276 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0005/20040005999.pdf [firstpage_image] =>[orig_patent_app_number] => 10384105 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6678134 [patent_doc_number] => 20030228274 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-11 [patent_title] => 'Polyamide chains of precise length' [patent_app_type] => new [patent_app_number] => 10/379585 [patent_app_country] => US [patent_app_date] => 2003-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23196 [patent_no_of_claims] => 76 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0228/20030228274.pdf [firstpage_image] =>[orig_patent_app_number] => 10379585 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 741417 [patent_doc_number] => 07030082 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-04-18 [patent_title] => 'Pharmaceutical compositions of drug-oligomer conjugates and methods of treating disease therewith' [patent_app_type] => utility [patent_app_number] => 10/382069 [patent_app_country] => US [patent_app_date] => 2003-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 33322 [patent_no_of_claims] => 72 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/030/07030082.pdf [firstpage_image] =>[orig_patent_app_number] => 10382069 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7388725 [patent_doc_number] => 20040030101 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-12 [patent_title] => 'Interferon conjugates' [patent_app_type] => new [patent_app_number] => 10/377892 [patent_app_country] => US [patent_app_date] => 2003-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5265 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0030/20040030101.pdf [firstpage_image] =>[orig_patent_app_number] => 10377892 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6730865 [patent_doc_number] => 20030187055 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-02 [patent_title] => 'Synergistic pharmaceutical combinations for treating obesity' [patent_app_type] => new [patent_app_number] => 10/373726 [patent_app_country] => US [patent_app_date] => 2003-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3103 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20030187055.pdf [firstpage_image] =>[orig_patent_app_number] => 10373726 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6804995 [patent_doc_number] => 20030232389 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-18 [patent_title] => 'Urokinase peptide structure mimetics' [patent_app_type] => new [patent_app_number] => 10/362184 [patent_app_country] => US [patent_app_date] => 2003-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8182 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20030232389.pdf [firstpage_image] =>[orig_patent_app_number] => 10362184 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 701122 [patent_doc_number] => 07063842 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-06-20 [patent_title] => 'Compounds and methods for inhibiting the interaction between α-catenin and β-catenin' [patent_app_type] => utility [patent_app_number] => 10/369226 [patent_app_country] => US [patent_app_date] => 2003-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 17028 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/063/07063842.pdf [firstpage_image] =>[orig_patent_app_number] => 10369226 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1027814 [patent_doc_number] => 06881553 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-04-19 [patent_title] => 'Antimicrobial activity of gemfibrozil and related compounds and derivatives and metabolites thereof' [patent_app_type] => utility [patent_app_number] => 10/366686 [patent_app_country] => US [patent_app_date] => 2003-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 57 [patent_figures_cnt] => 62 [patent_no_of_words] => 28549 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 354 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/881/06881553.pdf [firstpage_image] =>[orig_patent_app_number] => 10366686 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7290687 [patent_doc_number] => 20040110665 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-10 [patent_title] => 'Desleucyl glycopeptide antibiotics and methods of making same' [patent_app_type] => new [patent_app_number] => 10/361603 [patent_app_country] => US [patent_app_date] => 2003-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18338 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20040110665.pdf [firstpage_image] =>[orig_patent_app_number] => 10361603 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7150901 [patent_doc_number] => 20040171554 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-02 [patent_title] => 'Compositions and methods for enhancing apoptosis' [patent_app_type] => new [patent_app_number] => 10/364645 [patent_app_country] => US [patent_app_date] => 2003-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 25771 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20040171554.pdf [firstpage_image] =>[orig_patent_app_number] => 10364645 [rel_patent_id] =>[rel_patent_doc_number] =>)